CYTOVIA Therapeutics and the New York Stem Cell Foundation Research Institute enter into a partnership to develop iPSC derived CAR NK Therapeutics NEW YORK, Jan. 09, 2020 (GLOBE NEWSWIRE) -- The New York Stem Cell Foundation (NYSCF) Research Institute today announced a partnership with Cytovia Therapeutics Inc. (Cytovia) to develop new disease...

New Cloud-Based Service Makes it Easy for Companies to Share Hazardous Chemical Information With First Responders CHICAGO, Feb. 12, 2015 (GLOBE NEWSWIRE) -- MSDSonline, the leading cloud-based hazardous chemical management solutions provider, is reminding companies working to meet the EPA's Tier II chemical...